Three cases report and literature review of X-Linked agammaglobulinemia
10.3969/j.issn.1000-3606.2014.07.023
- VernacularTitle:X-连锁无丙种球蛋白血症3例报告并文献复习
- Author:
Xiaolin LI
;
Simao FU
;
Yuling LIU
;
Li ZHANG
;
Guomo LIN
;
Xiaofen PAN
- Publication Type:Journal Article
- Keywords:
X-linked agammaglobulinemia;
arthritis;
hypogammaglobulinemia;
primary immunodeficiency;
immunoglobulin
- From:
Journal of Clinical Pediatrics
2014;(7):690-693
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical features, diagnosis and treatment of X-Linked Agarnmaglobulinemia (XLA). Methods Clinical features, cellular and humoral immune functions, treatment and prognosis from 3 patients with XLA were retrospectively reviewed. Results The age of onset were from 11 months to 6 years in these 3 cases, however, the median age of diagnosis was 12 years. All patients showed multiple recurrent bacterial infections, arthritis involved large joints such as knee, ankle, elbow and hip. Laboratory examination revealed the decrease of serum gammmaglohulin and absence of B lymphocytes in the peripheral blood. All 3 patients were identiifed BTK mutations, which were frameshift mutation and nonsense mutation in exon 3, frameshift mutation in exon 10, missense mutation in exon 18. After XLA was diagnosed, the patients were managed by intravenous gammagloulin (IVIG) replacement. The non-steroidal anti-inflammatory drugs (NSAIDs) were administrated in patients combined arthritis. The small dose of hormones had been applied. All patients had a significantly improvement. Conclusions The clinical features of XLA have greater variability, with recurrent bacterial infections. Markedly decreased and absent tosils and lymph nodes, serum immunoglobulin may be one of the warning signs for early diagnosis of XLA. IVIG and NSAIDs can be jointly treatment of XLA with arthritis. The steroid and immunosuppressant agents should be used with caution.
